Guangdong Biolight Meditech Co., Ltd. (300246.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.14B
Enterprise Value2.27B
P/E Ratio-55.94
PEG Ratio1.4
Price/Sales Ratio4.67
Price/Book Ratio4.46
Enterprise/Revenue4.95
Enterprise/EBITDA-403.36

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.08
Operating Margin-0.07
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.08

Income Statement

Revenue1.1B
Revenue/Share4.17
Gross Profit281.53M
EBITDA27.35M
Net Income-69.43M
Diluted EPS-0.26

Balance Sheet

Total Cash577.33M
Total Cash/Share2.21
Total Debt756.05M
Total Debt/Equity0.67
Current Ratio1.46
Book Value Per Share4.61

Price History

52-Week Change97.94
52-Week High21.98
52-Week Low7.67
Moving Average 50 Days16.62
Moving Average 200 Days13.57

Statistics

Average Volume14.7M
Shares Outstanding264.61M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.26
Payout Ratio-0.25
Last Split Factor3:2
Last Split DateMay 25, 2023
AD